Mission The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2017 employed about 94,000 people worldwide. In 2017, Roche invested CHF 10.4 billion in R&D and posted sales of CHF 53.3 billion. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan.
Doing now what patients need next
For more information, please visit http://www.roche.com/careers
Description Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.
Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders.
GSK is a global biopharma company with a special purpose – to unite science, technology and talent to get ahead of disease together – so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns – as an organisation where people can thrive. Getting ahead means preventing disease as well as treating it, and we aim to impact the health of 2.5 billion people around the world in the next 10 years.
NOTICE: Salary ranges on this site are estimates provided by Glassdoor and have not been verified by GSK. GSK Recruiters will share the salary range during the Recruitment process.
Viatris is a global healthcare company formed in 2020 through the combination of Mylan and Upjohn, a legacy division of Pfizer. By integrating the strengths of these two companies, including our global workforce of ~45,000, we aim to deliver increased access to affordable, quality medicines for patients worldwide, regardless of geography or circumstance.
We believe in healthcare as it should be – empowering people worldwide to live healthier at every stage of life. Because of our unwavering belief that better access leads to better health, we leverage our best-in-class manufacturing and scientific expertise and proven commercial capabilities to bring quality medicines to patients when and where they need them.
Born in the North East in 2004, CPI was initially funded by UK Regional Development Agency ONE NorthEast to support the growth and development of advanced manufacturing in the UK by translating research from academia through technology readiness levels to commercial feasibility – also known as bridging the 'valley of death'.
Since then, we've evolved into a team of radical thinkers solving the biggest global challenges in healthcare and sustainability through science and technology innovation. Today, CPI consists of ten national innovation centres and regional offices, each with its own incredible capabilities spanning AgriFoodTech, energy storage, HealthTech, sustainable materials, and pharma. We do this not only through our innovation expertise and infrastructure, but also by supporting our communities with STEM skills, industry foresighting, investing in promising early-stage deep tech companies, and through partnerships with investors, academia, and government.
Since 2011, we’ve operated as a founding member of the High Value Manufacturing (HVM) Catapult, alongside the Manufacturing Technology Centre, Warwick Manufacturing Group, Advanced Manufacturing Research Centre, Nuclear AMRC, National Manufacturing Institute Scotland, and the National Composites Centre.
We receive approximately one-third of our funding from the HVM Catapult, with the rest of our income from commercial and collaborative research and development projects. As a social enterprise, our profits are reinvested in our people and projects to catalyse even more innovations that improve our world.
We are devoted to providing the highest standard of support and care for the individuals and families we serve.
Individualised Care – personalised support for every child and adult
Professional Engagement – working together with families and experts
Safe and Welcoming Homes – comfortable, secure environments to thrive
Building Resilience – empowering independence and confidence
Skilled and Dedicated Teams – qualified professionals delivering quality care
Roche has an employee rating of 4.1 out of 5 stars, based on 6,438 company reviews on Glassdoor which indicates that most employees have an excellent working experience there. The Roche employee rating is in line with the average (within 1 standard deviation) for employers within the Pharmaceutical and biotechnology industry (3.5 stars).
To get a job at Roche, browse currently open positions and apply for a job near you. Once you get a positive response, make sure to find out about the interview process at Roche and prepare for tough questions.
Overall, 82% of employees would recommend working at Roche to a friend. This is based on 8,571 anonymously submitted reviews on Glassdoor.
68% of job seekers rate their interview experience at Roche as positive. Candidates give an average difficulty score of 3 out of 5 (where 5 is the highest level of difficulty) for their job interview at Roche.